Concepedia

Chureen T. Carter

CT

Statistics

Publications

4

Citations

161

H-Index

4

Active since

2011

Affiliations

Janssen (United States)(Current)

Chureen T. Carter is an author at Janssen (United States) specializing in pharmacy, inflammatory bowel disease, and health services research.

Publications per year

2011–2019

4

Publications

4

Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: The mHealth Screening To Prevent Strokes (mSToPS) trial

Steven R. Steinhubl, Rajesh Mehta, Gail S. Ebner et al. · American Heart Journal · 2016 · 58 citations · Full text

, , +17

Impact of infliximab adherence on Crohn’s disease-related healthcare utilization and inpatient costs

Chureen T. Carter, Heidi C. Waters, Daniel B. Smith · Advances in Therapy · 2011 · 47 citations

, , +16

Digital recruitment and enrollment in a remote nationwide trial of screening for undiagnosed atrial fibrillation: Lessons from the randomized, controlled mSToPS trial

Katie Baca-Motes, Alison Edwards, Jill Waalen et al. · Contemporary Clinical Trials Communications · 2019 · 35 citations · Full text

, , +17

Impact of persistence with infliximab on hospitalizations in ulcerative colitis.

Chureen T. Carter, Henry Leher, Paula Marincola Smith et al. · PubMed · 2011 · 21 citations

, , +16

1–4 of 4